| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |